CYP3A5
Gastrointestinal & Hepatic System · Phase I & Phase II Xenobiotic Detoxification
How is CYP3A5 related to drug metabolism?
CYP3A5 encodes an enzyme that processes certain medicines and steroid hormones. The practical meaning of a finding depends on which drug is involved and whether the tested variants establish an interpretable enzyme-activity pattern.
- Common Gene Name
- cytochrome P450 family 3 subfamily A member 5
- NCBI Gene ID
- 1577
- Chromosome
- 7
Clinical Evidence Status
Drug-response evidence availableTumor or drug-label biomarker context
These labels describe available evidence about a gene. They do not classify your variant or recommend a treatment.
Answer Sources
Explore supporting evidence (3 records)
| Condition or drug | Evidence | Grade / status | Context | Source |
|---|---|---|---|---|
| Tacrolimus | FDA pharmacogenetics | Management recommendation | Drug-specific subgroup | View source |
| Prasugrel (3) | FDA labeling biomarker | Label mentions biomarker; actionability not inferred | Cardiology | View source |
| Tacrolimus | FDA labeling biomarker | Label mentions biomarker; actionability not inferred | Transplantation | View source |
Source snapshot: 2026-09-09. Consumer text updated: 2026-09-10. Source dates describe the cited records, not a new clinical review.
← Back to Gastrointestinal & Hepatic System